202 related articles for article (PubMed ID: 19053635)
1. Highly accelerated self-assembly and fibrillation of prion peptides on solid surfaces.
Ku SH; Park CB
Langmuir; 2008 Dec; 24(24):13822-7. PubMed ID: 19053635
[TBL] [Abstract][Full Text] [Related]
2. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
Walsh P; Yau J; Simonetti K; Sharpe S
Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
[TBL] [Abstract][Full Text] [Related]
3. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M
Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954
[TBL] [Abstract][Full Text] [Related]
4. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro.
Liu YH; Han YL; Song J; Wang Y; Jing YY; Shi Q; Tian C; Wang ZY; Li CP; Han J; Dong XP
Int J Biochem Cell Biol; 2011 May; 43(5):768-74. PubMed ID: 21296677
[TBL] [Abstract][Full Text] [Related]
6. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
7. Influence of dendrimer's structure on its activity against amyloid fibril formation.
Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M
Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918
[TBL] [Abstract][Full Text] [Related]
8. Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein.
Lee SW; Mou Y; Lin SY; Chou FC; Tseng WH; Chen CH; Lu CY; Yu SS; Chan JC
J Mol Biol; 2008 May; 378(5):1142-54. PubMed ID: 18423487
[TBL] [Abstract][Full Text] [Related]
9. An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds.
Boshuizen RS; Langeveld JP; Salmona M; Williams A; Meloen RH; Langedijk JP
Anal Biochem; 2004 Oct; 333(2):372-80. PubMed ID: 15450815
[TBL] [Abstract][Full Text] [Related]
10. Small stress molecules inhibit aggregation and neurotoxicity of prion peptide 106-126.
Kanapathipillai M; Ku SH; Girigoswami K; Park CB
Biochem Biophys Res Commun; 2008 Jan; 365(4):808-13. PubMed ID: 18039468
[TBL] [Abstract][Full Text] [Related]
11. Template-directed self-assembly and growth of insulin amyloid fibrils.
Ha C; Park CB
Biotechnol Bioeng; 2005 Jun; 90(7):848-55. PubMed ID: 15803463
[TBL] [Abstract][Full Text] [Related]
12. A fluorescent mutant of the NM domain of the yeast prion Sup35 provides insight into fibril formation and stability.
Palhano FL; Rocha CB; Bernardino A; Weissmuller G; Masuda CA; Montero-Lomelí M; Gomes AM; Chien P; Fernandes PM; Foguel D
Biochemistry; 2009 Jul; 48(29):6811-23. PubMed ID: 19530740
[TBL] [Abstract][Full Text] [Related]
13. Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers.
Heegaard PM; Pedersen HG; Flink J; Boas U
FEBS Lett; 2004 Nov; 577(1-2):127-33. PubMed ID: 15527773
[TBL] [Abstract][Full Text] [Related]
14. Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways.
Natalello A; Prokorov VV; Tagliavini F; Morbin M; Forloni G; Beeg M; Manzoni C; Colombo L; Gobbi M; Salmona M; Doglia SM
J Mol Biol; 2008 Sep; 381(5):1349-61. PubMed ID: 18619462
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy.
Anderson M; Bocharova OV; Makarava N; Breydo L; Salnikov VV; Baskakov IV
J Mol Biol; 2006 Apr; 358(2):580-96. PubMed ID: 16519898
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous beta-helical fold in prion protein: the case of PrP(82-146).
Saracino GA; Villa A; Moro G; Cosentino U; Salmona M
Proteins; 2009 Jun; 75(4):964-76. PubMed ID: 19089953
[TBL] [Abstract][Full Text] [Related]
17. A single prion protein peptide can elicit a panel of isoform specific monoclonal antibodies.
Vranac T; Hartman KP; Popović M; Venturini A; Zerovnik E; Curin Serbec V
Peptides; 2006 Nov; 27(11):2695-705. PubMed ID: 16859811
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into alternate aggregated prion protein forms.
Polano M; Bek A; Benetti F; Lazzarino M; Legname G
J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
Nazabal A; Hornemann S; Aguzzi A; Zenobi R
J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
[TBL] [Abstract][Full Text] [Related]
20. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
Jones EM; Surewicz WK
Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
